Dextrose 2.5% and Sodium Chloride 0.11% in a plastic container is a sterile solution used for intravenous fluid administration. It combines dextrose, a simple sugar that provides calories, with sodium chloride, an electrolyte that helps maintain fluid balance [1].
Why is this solution used?
This intravenous solution serves as a source of hydration and calories. It is often administered to patients who cannot take sufficient fluids or nutrients by mouth, or to help correct electrolyte imbalances [2]. The dextrose component can help prevent hypoglycemia, particularly in situations where a patient may be NPO (nothing by mouth) [1]. The sodium chloride contributes to maintaining extracellular fluid volume and osmotic pressure [2].
What is the difference between Dextrose 2.5% and other dextrose solutions?
Dextrose solutions are available in various concentrations, such as D5W (5% dextrose in water), D10W (10% dextrose in water), and hypertonic dextrose solutions. Dextrose 2.5% is a hypotonic solution, meaning it has a lower solute concentration than blood. This makes it suitable for rehydration and providing a modest caloric source without causing significant fluid shifts into or out of cells [2]. Higher concentrations of dextrose are used for more substantial caloric support or to treat specific metabolic conditions [1].
How is Dextrose 2.5% and Sodium Chloride 0.11% administered?
The solution is administered intravenously, typically through a peripheral IV catheter or a central venous line. The rate and volume of administration are determined by a healthcare professional based on the patient's specific medical condition, fluid and electrolyte needs, and overall clinical status [2].
What are the risks associated with using this solution?
As with any intravenous fluid therapy, there are potential risks. These include fluid overload, electrolyte imbalances (if administered improperly or in excessive amounts), and localized reactions at the IV site, such as phlebitis or infiltration. In patients with certain medical conditions, such as diabetes, the dextrose component requires careful monitoring to avoid hyperglycemia [1][2].
When does the patent expire for this type of product?
Products like Dextrose 2.5% and Sodium Chloride 0.11% are generally considered basic intravenous solutions. The active ingredients, dextrose and sodium chloride, are well-established and not subject to patent protection for their general therapeutic use. Patents typically apply to novel drug formulations, delivery systems, or specific medical uses. Therefore, there are no specific patent expiry dates for the fundamental composition of these solutions [3].
Who manufactures Dextrose 2.5% and Sodium Chloride 0.11%?
Numerous pharmaceutical companies manufacture sterile intravenous solutions, including those containing dextrose and sodium chloride. Major suppliers include companies like Baxter Healthcare, Fresenius Kabi, and B. Braun Medical Inc. [3].
Sources:
[1] https://www.drugpatentwatch.com
[2] https://www.drugpatentwatch.com
[3] https://www.drugpatentwatch.com